CTLA4 and neoplasm: A recent study on non-small cell lung cancer (NSCLC) showed that increased cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) in the tumor microenvironment could suppress the function of dendritic cells (DCs), resulting in immunosuppressive effects (Russick et al., 2020).